SOEN yields 2000000.00% · JNJ yields 2.14%● Live data
📍 SOEN pulled ahead of the other in Year 1
Combined, SOEN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SOEN + JNJ for your $10,000?
Solar EnerTech Corp. operates as a photovoltaic (PV) solar energy cell manufacturing company. Its principal products include monocrystalline silicon and polycrystalline silicon solar cells and modules. The company's solar cells convert sunlight to electricity through the PV effect. It also designs and produces advanced PV modules for various applications, such as standard panels for solar power stations, roof panels, solar arrays, and modules incorporated directly into exterior walls. The company markets its products primarily to solar panel installers, who incorporate those modules into their power generating systems that are sold to end-customers located in Europe, Australia, North America, and China. It markets its solar cells and modules under the SolarE brand name. The company was formerly known as Safer Residence Corporation and changed its name to Solar EnerTech Corp. in April 2006. Solar EnerTech Corp. was incorporated in 2004 is headquartered in Mountain View, California.
Full SOEN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.